A detailed history of Silverarc Capital Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 495,471 shares of WVE stock, worth $2.47 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
495,471
Holding current value
$2.47 Million
% of portfolio
1.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.54 - $6.84 $1.75 Million - $3.39 Million
495,471 New
495,471 $3.06 Million
Q4 2022

Feb 14, 2023

BUY
$3.18 - $7.0 $159,000 - $350,000
50,000 New
50,000 $350,000
Q3 2021

Nov 15, 2021

SELL
$4.89 - $7.12 $606,223 - $882,680
-123,972 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$5.65 - $7.47 $474,441 - $627,270
83,972 Added 209.93%
123,972 $826,000
Q1 2021

May 18, 2021

BUY
$5.61 - $12.01 $224,400 - $480,400
40,000 New
40,000 $224,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $433M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Silverarc Capital Management, LLC Portfolio

Follow Silverarc Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.